Media Thread, page-10439

Yup. A very interesting interview. You report her comments accurately.

I was also interested to hear her say, with regard to turning cold tumours hot so that they are seen by the immune system - "and that's exactly what our product does.". So that's good to hear.

In addition, wiith regard to the last MAST dose escalation, she reaffirms that: "you can only dose escalate, to find that perfect dose, if each of the cohorts are free from any safety issues and/or you've seen some level of signals or efficacy that it's starting to really work in the patient. And so we are announcing today that we are at a fairly mid to high dose, because we wanna take this as much as we can and we are at a fairly high dose. So we've been able to do this quite successfully across many many solid cancer types."

That's about as big a hint as she can give that this is working. Waiting for the actual result data requires patience, but I'm fine with that.

Cheers

Dave